Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.

Anil K Agarwal1, Vinaya Simha, Elif Arioglu Oral

  • 1Department of Internal Medicine, Division of Nutrition and Metabolic Diseases and Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.

The Journal of Clinical Endocrinology and Metabolism
|October 15, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Familial Generalized and Partial Lipodystrophies Due to Rare Biallelic Variants in <i>LMNA</i>.

International journal of molecular sciences·2026
Same author

Genotype-Phenotype Heterogeneity Among Patients with Lipodystrophy Harboring Rare POLD1 Variants.

The Journal of clinical endocrinology and metabolism·2026
Same author

Novel Homozygous Variants in CIDEC and WRN in a Young Female with Lipodystrophy and Thyroid Cancer.

International journal of molecular sciences·2026
Same author

Response to letter to the editor by Matsubara and colleagues.

Journal of clinical lipidology·2026
Same author

Effects of glucagon-like peptide-1 agonist therapy on vertebral bone mineral density as measured by CT-based Hounsfield units.

Journal of neurosurgery. Spine·2025
Same author

Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directions.

Expert review of endocrinology & metabolism·2025
Same journal

Continuous glucose monitoring-derived time in range is associated with changes in arterial stiffness in type 2 diabetes.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Association of the Primary Aldosteronism Severity Classification with Lateralization and Treatment Outcomes.

The Journal of clinical endocrinology and metabolism·2026
Same journal

From Premature Adrenarche to Adult Metabolic Risk and Hyperandrogenism: A Systematic Review and Meta-Analysis.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Open-Label 9-Year Follow-Up Extension Phase 2 Study of Once-Weekly Somatrogon in Children With Growth Hormone Deficiency.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Correction to: "CAHQL: A Patient-Reported Outcome Instrument to Assess Health-Related Quality of Life in Congenital Adrenal Hyperplasia".

The Journal of clinical endocrinology and metabolism·2026
Same journal

Approach to Personalizing the Treatment of Osteoporosis.

The Journal of clinical endocrinology and metabolism·2026
See all related articles
This summary is machine-generated.

Congenital generalized lipodystrophy (CGL) is a rare genetic disorder. Mutations in AGPAT2 and BSCL2 genes cause CGL, but other genetic causes may exist, leading to varied symptoms.

Area of Science:

  • Genetics
  • Endocrinology
  • Rare Diseases

Background:

  • Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder.
  • Characterized by near-complete absence of adipose tissue from birth.
  • Mutations in AGPAT2 and BSCL2 genes are known causes of CGL.

Purpose of the Study:

  • Investigate genetic heterogeneity in CGL.
  • Identify potential new loci for CGL.
  • Compare phenotypes across different CGL subtypes.

Main Methods:

  • Genotyping of 45 CGL pedigrees for AGPAT2 and BSCL2.
  • Mutation analysis and identification of novel variants.
  • Phenotypic comparison between CGL subtypes.

Main Results:

Related Experiment Videos

  • Mutations in AGPAT2 found in 26 pedigrees (7 novel variants).
  • Mutations in BSCL2 found in 11 pedigrees (5 novel variants).
  • Eight pedigrees had no alterations in AGPAT2 or BSCL2, suggesting other loci.

Conclusions:

  • Genetic heterogeneity exists in CGL, with potential additional loci beyond AGPAT2 and BSCL2.
  • Phenotypic heterogeneity is observed among CGL subtypes.
  • BSCL2 mutations are associated with lower leptin, earlier diabetes onset, and mild mental retardation.